133 related articles for article (PubMed ID: 25200358)
21. Efficacy of combined surgery and
Wu ZY; Wu WJ; Zheng L; Huang MW; Shi Y; Lv XM; Liu SM; Zhang JG; Zhang J
Head Neck; 2019 Sep; 41(9):3219-3225. PubMed ID: 31116488
[TBL] [Abstract][Full Text] [Related]
22. [
Yu HB; Wu WJ; Lv XM; Shi Y; Zheng L; Zhang JG
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):919-923. PubMed ID: 33047730
[TBL] [Abstract][Full Text] [Related]
23. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
[TBL] [Abstract][Full Text] [Related]
24. Three-dimensional verification of ¹²⁵I seed stability after permanent implantation in the parotid gland and periparotid region.
Fan Y; Huang MW; Zheng L; Zhao YJ; Zhang JG
Radiat Oncol; 2015 Nov; 10():242. PubMed ID: 26597296
[TBL] [Abstract][Full Text] [Related]
25. A reliable skin toxicity predictor in permanent breast seed implant brachytherapy.
Anjomani Z; Hilts M; Batchelar D; Crook J
Brachytherapy; 2020; 19(5):685-693. PubMed ID: 32739213
[TBL] [Abstract][Full Text] [Related]
26. Radiation-related Adverse Effects of CT-guided Implantation of
Ji Z; Jiang Y; Guo F; Peng R; Sun H; Wang P; Fan J; Wang J
Sci Rep; 2019 Oct; 9(1):14803. PubMed ID: 31616052
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
[TBL] [Abstract][Full Text] [Related]
28. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
29. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
30. Clinical effectiveness of 125I-seed implantation in combination with nimotuzumab therapy for the advanced oral carcinoma: preliminary results.
Meng J; Wang X; Zhuang QW; Gu QP; Zhang J; Li ZP
Eur Rev Med Pharmacol Sci; 2014; 18(21):3304-10. PubMed ID: 25487943
[TBL] [Abstract][Full Text] [Related]
31. Radioactive seed migration following parotid gland interstitial brachytherapy.
Fan Y; Huang MW; Zhao YJ; Gao H; Zhang JG
Brachytherapy; 2017; 16(6):1219-1224. PubMed ID: 28927732
[TBL] [Abstract][Full Text] [Related]
32. 125I Seed Implant Brachytherapy for Painful Bone Metastases After Failure of External Beam Radiation Therapy.
Feng S; Wang L; Xiao Z; Maharjan R; Chuanxing L; Fujun Z; Jinhua H; Peihong W
Medicine (Baltimore); 2015 Aug; 94(31):e1253. PubMed ID: 26252288
[TBL] [Abstract][Full Text] [Related]
33. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
34. The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.
Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y
Jpn J Radiol; 2016 Nov; 34(11):718-723. PubMed ID: 27631882
[TBL] [Abstract][Full Text] [Related]
35. Mandibular growth in survivors of pediatric parotid gland carcinoma treated with interstitial brachytherapy.
Wu WJ; Huang MW; Zhang GH; Zhao D; Zheng L; Yu GY; Zhang JG
Pediatr Blood Cancer; 2018 Sep; 65(9):e27223. PubMed ID: 29797637
[TBL] [Abstract][Full Text] [Related]
36. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
[TBL] [Abstract][Full Text] [Related]
37. Iodine 125 versus palladium 103 implants for prostate cancer: clinical outcomes and complications.
Peschel RE; Colberg JW; Chen Z; Nath R; Wilson LD
Cancer J; 2004; 10(3):170-4. PubMed ID: 15285926
[TBL] [Abstract][Full Text] [Related]
38. Brachytherapy in patients with small prostate glands.
Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
[TBL] [Abstract][Full Text] [Related]
39. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
Pickett B; Pouliot J
Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
[TBL] [Abstract][Full Text] [Related]
40. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.
Merrick GS; Butler WM; Dorsey AT; Lief JH; Donzella JG
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1069-74. PubMed ID: 11072164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]